292 related articles for article (PubMed ID: 25154780)
1. Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06.
Eichmann M; de Ru A; van Veelen PA; Peakman M; Kronenberg-Versteeg D
Tissue Antigens; 2014 Oct; 84(4):378-88. PubMed ID: 25154780
[TBL] [Abstract][Full Text] [Related]
2. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.
Weichold FF; Mueller S; Kortsik C; Hitzler WE; Wulf MJ; Hone DM; Sadoff JC; Maeurer MJ
Genes Immun; 2007 Jun; 8(4):334-43. PubMed ID: 17429413
[TBL] [Abstract][Full Text] [Related]
3. Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants.
Bade-Doeding C; DeLuca DS; Seltsam A; Blasczyk R; Eiz-Vesper B
Immunogenetics; 2007 Apr; 59(4):253-9. PubMed ID: 17294180
[TBL] [Abstract][Full Text] [Related]
4. The composition of the F pocket in HLA-A*74 generates C-terminal promiscuity among its bound peptides.
Bade-Doeding C; Huyton T; Eiz-Vesper B; Blasczyk R
Tissue Antigens; 2011 Nov; 78(5):378-81. PubMed ID: 21762397
[TBL] [Abstract][Full Text] [Related]
5. The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles.
Muixí L; Gay M; Muñoz-Torres PM; Guitart C; Cedano J; Abian J; Alvarez I; Jaraquemada D
Genes Immun; 2011 Oct; 12(7):504-12. PubMed ID: 21654843
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of the Endogenous Peptidomes Displayed by HLA-B*27 and Mamu-B*08: Two MHC Class I Alleles Associated with Elite Control of HIV/SIV Infection.
Marcilla M; Alvarez I; Ramos-Fernández A; Lombardía M; Paradela A; Albar JP
J Proteome Res; 2016 Mar; 15(3):1059-69. PubMed ID: 26811146
[TBL] [Abstract][Full Text] [Related]
7. Presence of strong association of the major histocompatibility complex (MHC) class I allele HLA-A*26:01 with idiopathic hypoparathyroidism.
Goswami R; Singh A; Gupta N; ; Rani R
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1820-4. PubMed ID: 22723329
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome.
Schellens IM; Hoof I; Meiring HD; Spijkers SN; Poelen MC; van Gaans-van den Brink JA; van der Poel K; Costa AI; van Els CA; van Baarle D; Kesmir C
PLoS One; 2015; 10(9):e0136417. PubMed ID: 26375851
[TBL] [Abstract][Full Text] [Related]
9. Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P.
Bade-Doeding C; Cano P; Huyton T; Badrinath S; Eiz-Vesper B; Hiller O; Blasczyk R
Hum Immunol; 2011 Nov; 72(11):1039-44. PubMed ID: 21872626
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism between HLA-A*0301 and A*0302 located outside the pocket F alters the PΩ peptide motif.
Elamin NE; Bade-Doeding C; Blasczyk R; Eiz-Vesper B
Tissue Antigens; 2010 Dec; 76(6):487-90. PubMed ID: 20707881
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
Griffin TA; Yuan J; Friede T; Stevanovic S; Ariyoshi K; Rowland-Jones SL; Rammensee HG; Colbert RA
J Immunol; 1997 Nov; 159(10):4887-97. PubMed ID: 9366414
[TBL] [Abstract][Full Text] [Related]
12. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
[TBL] [Abstract][Full Text] [Related]
13. The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.
Bade-Döding C; Theodossis A; Gras S; Kjer-Nielsen L; Eiz-Vesper B; Seltsam A; Huyton T; Rossjohn J; McCluskey J; Blasczyk R
Haematologica; 2011 Jan; 96(1):110-8. PubMed ID: 20934997
[TBL] [Abstract][Full Text] [Related]
14. The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.
Trolle T; McMurtrey CP; Sidney J; Bardet W; Osborn SC; Kaever T; Sette A; Hildebrand WH; Nielsen M; Peters B
J Immunol; 2016 Feb; 196(4):1480-7. PubMed ID: 26783342
[TBL] [Abstract][Full Text] [Related]
15. Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.
Manandhar T; Kunze-Schumacher H; Huyton T; Celik AA; Blasczyk R; Bade-Doeding C
Immunogenetics; 2016 Apr; 68(4):247-60. PubMed ID: 26758079
[TBL] [Abstract][Full Text] [Related]
16. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
17. Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population.
DiBrino M; Parker KC; Margulies DH; Shiloach J; Turner RV; Biddison WE; Coligan JE
Biochemistry; 1995 Aug; 34(32):10130-8. PubMed ID: 7543776
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of HLA binding affinity and ligand diversity: implications for generating immunodominant CD8+ T cell responses.
Rao X; Costa AI; van Baarle D; Kesmir C
J Immunol; 2009 Feb; 182(3):1526-32. PubMed ID: 19155500
[TBL] [Abstract][Full Text] [Related]
19. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
[TBL] [Abstract][Full Text] [Related]
20. Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs.
Escobar H; Crockett DK; Reyes-Vargas E; Baena A; Rockwood AL; Jensen PE; Delgado JC
J Immunol; 2008 Oct; 181(7):4874-82. PubMed ID: 18802091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
